{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:56:53Z","timestamp":1776808613437,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02391-w","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T22:02:50Z","timestamp":1661378570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Enzyme Responsive Delivery of Anti-Retroviral Peptide via Smart Hydrogel"],"prefix":"10.1208","volume":"23","author":[{"given":"Taj","family":"Yeruva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"2391_CR1","unstructured":"Global HIV & AIDS statistics \u2014 2020 fact sheet [Internet]. [cited 2021 Jan 3]. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet.\u00a0Accessed 16 Aug 2022"},{"key":"2391_CR2","unstructured":"20.1 million girls and women living with HIV [Internet]. [cited 2021 Jan 3]. Available from:\u00a0https:\/\/www.unaids.org\/en\/resources\/infographics\/girls-and-women-living-with-HIV.\u00a0Accessed 16 Aug 2022"},{"key":"2391_CR3","unstructured":"AIDSinfo | UNAIDS [Internet]. [cited 2020 Apr 8]. Available from:\u00a0https:\/\/aidsinfo.unaids.org\/.\u00a0Accessed 16 Aug 2022"},{"issue":"4","key":"2391_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018165","volume":"6","author":"UL Abbas","year":"2011","unstructured":"Abbas UL, Hood G, Wetzel AW, Mellors JW. Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP). PLoS ONE. 2011;6(4): e18165.","journal-title":"PLoS ONE"},{"issue":"8","key":"2391_CR5","first-page":"1211","volume":"211","author":"DA Lehman","year":"2015","unstructured":"Lehman DA, Baeten JM, McCoy CO, Weis JF, Peterson D, Mbara G, et al. Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single-or dual-agent preexposure prophylaxis. J Infect Dis. 2015;211(8):1211\u20138.","journal-title":"J Infect Dis"},{"issue":"6","key":"2391_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/aji.12240","volume":"71","author":"V Barreto-de-Souza","year":"2014","unstructured":"Barreto-de-Souza V, Arakelyan A, Margolis L, Vanpouille C. HIV-1 Vaginal transmission: cell-free or cell-associated virus? Am J Reprod Immunol. 2014 Jun;71(6):589\u201399.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"2391_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1089\/apc.2017.0201","volume":"32","author":"E Aaron","year":"2018","unstructured":"Aaron E, Blum C, Seidman D, Hoyt MJ, Simone J, Sullivan M, et al. Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care STDS. 2018;32(1):16\u201323.","journal-title":"AIDS Patient Care STDS"},{"key":"2391_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-med-090518-093731","volume":"71","author":"JM Baeten","year":"2020","unstructured":"Baeten JM, Hendrix CW, Hillier SL. Topical microbicides in HIV prevention: state of the promise. Annu Rev Med. 2020;71:361\u201377.","journal-title":"Annu Rev Med"},{"key":"2391_CR9","doi-asserted-by":"crossref","unstructured":"Musara P, Milford C, Shapley-Quinn MK, Weinrib R, Mutero P, Odoom E, et al. Preferences and acceptability of vaginal delivery forms for HIV prevention among women, male partners and key informants in South Africa and Zimbabwe: qualitative findings. AIDS Behavior. 2020;1\u201315.","DOI":"10.1007\/s10461-020-02949-4"},{"issue":"4","key":"2391_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5539\/ijb.v11n4p80","volume":"11","author":"W Fang","year":"2019","unstructured":"Fang W, Mphoyi BI, Motake DR, Liu J, Li W, Mei F, et al. Efficacy, adherence and side effects of PrEP for HIV-1 prevention. IJB. 2019 Aug 29;11(4):80.","journal-title":"IJB"},{"issue":"49","key":"2391_CR11","doi-asserted-by":"publisher","first-page":"17861","DOI":"10.1021\/jacs.7b08465","volume":"139","author":"K Nadendla","year":"2017","unstructured":"Nadendla K, Friedman SH. Light control of protein solubility through isoelectric point modulation. J Am Chem Soc. 2017 Dec 13;139(49):17861\u20139.","journal-title":"J Am Chem Soc"},{"issue":"7","key":"2391_CR12","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1021\/acs.molpharmaceut.9b00140","volume":"16","author":"K Nadendla","year":"2019","unstructured":"Nadendla K, Sarode BR, Friedman SH. Hydrophobic tags for highly efficient light-activated protein release. Mol Pharmaceutics. 2019 Jul 1;16(7):2922\u20138.","journal-title":"Mol Pharmaceutics"},{"key":"2391_CR13","doi-asserted-by":"crossref","unstructured":"Nadendla K, Sarode B, Friedman SH. Chemical modification of proteins with photocleavable groups. In: Methods in enzymology. Elsevier; 2019. p. 113\u201328.","DOI":"10.1016\/bs.mie.2019.04.008"},{"issue":"30","key":"2391_CR14","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.1016\/j.biomaterials.2009.07.043","volume":"30","author":"AA Aimetti","year":"2009","unstructured":"Aimetti AA, Machen AJ, Anseth KS. Poly (ethylene glycol) hydrogels formed by thiol-ene photopolymerization for enzyme-responsive protein delivery. Biomaterials. 2009;30(30):6048\u201354.","journal-title":"Biomaterials"},{"issue":"51","key":"2391_CR15","doi-asserted-by":"publisher","first-page":"14048","DOI":"10.1002\/ange.201308174","volume":"125","author":"MA Azagarsamy","year":"2013","unstructured":"Azagarsamy MA, Anseth KS. Wavelength-controlled photocleavage for the orthogonal and sequential release of multiple proteins. Angew Chem. 2013;125(51):14048\u201352.","journal-title":"Angew Chem"},{"issue":"4","key":"2391_CR16","doi-asserted-by":"publisher","first-page":"895a","DOI":"10.1093\/clinchem\/44.4.895a","volume":"44","author":"TJ Wang","year":"1998","unstructured":"Wang TJ, Rittenhouse HG, Wolfert RL, Lynne CM, Brackett NL. PSA concentrations in seminal plasma. Clin Chem. 1998;44(4):895a\u2013896.","journal-title":"Clin Chem"},{"key":"2391_CR17","doi-asserted-by":"crossref","unstructured":"Chan W, White P. Fmoc solid phase peptide synthesis: a practical approach. Oxford University Press; 1999. 371 p.","DOI":"10.1093\/oso\/9780199637256.001.0001"},{"key":"2391_CR18","unstructured":"Nadendla VSK. Second Generation Photoactivated Insulins [Internet] [Ph.D.]. ProQuest dissertations and theses. [Ann Arbor]: University of Missouri - Kansas City; 2020. Available from:\u00a0http:\/\/proxy.library.umkc.edu\/login?url=https:\/\/www.proquest.com\/dissertations-theses\/second-generation-photoactivated-insulins\/docview\/2423778183\/se-2?accountid=14589.\u00a0Accessed 16 Aug 2022"},{"issue":"40","key":"2391_CR19","doi-asserted-by":"publisher","first-page":"16401","DOI":"10.1021\/jacs.1c03681","volume":"143","author":"TA Hakala","year":"2021","unstructured":"Hakala TA, Yates EV, Challa PK, Toprakcioglu Z, Nadendla K, Matak-Vinkovic D, et al. Accelerating reaction rates of biomolecules by using shear stress in artificial capillary systems. J Am Chem Soc. 2021 Oct 13;143(40):16401\u201310.","journal-title":"J Am Chem Soc"},{"key":"2391_CR20","unstructured":"Yeruva TK. Smart hydrogel for enzyme responsive vaginal delivery of anti-HIV peptide therapeutics [Internet] [Ph.D.]. ProQuest Dissertations and Theses. [Ann Arbor]: University of Missouri - Kansas City; 2021. Available from: https:\/\/www.proquest.com\/dissertations-theses\/smart-hydrogel-enzyme-responsive-vaginal-delivery\/docview\/2615117404\/se-2?accountid=14696.\u00a0Accessed 16 Aug 2022"},{"issue":"21","key":"2391_CR21","first-page":"4924","volume":"57","author":"SR Denmeade","year":"1997","unstructured":"Denmeade SR, Lou W, L\u00f6vgren J, Malm J, Lilja H, Isaacs JT. Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. Can Res. 1997;57(21):4924\u201330.","journal-title":"Can Res"},{"issue":"10","key":"2391_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1517\/17425247.2011.600119","volume":"8","author":"T Yu","year":"2011","unstructured":"Yu T, Malcolm K, Woolfson D, Jones DS, Andrews GP. Vaginal gel drug delivery systems: understanding rheological characteristics and performance. Expert Opin Drug Deliv. 2011;8(10):1309\u201322.","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"2391_CR23","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/jps.23886","volume":"103","author":"C Zhang","year":"2014","unstructured":"Zhang C, Zhang T, Oyler NA, Youan BBC. Direct and real-time quantification of tenofovir release from pH-sensitive microparticles into simulated biological fluids using 1H-NMR. J Pharm Sci. 2014 Apr;103(4):1170\u20137.","journal-title":"J Pharm Sci"},{"issue":"2","key":"2391_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","volume":"59","author":"DH Owen","year":"1999","unstructured":"Owen DH, Katz DF. A vaginal fluid simulant. Contraception. 1999 Feb 1;59(2):91\u20135.","journal-title":"Contraception"},{"issue":"2","key":"2391_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2165\/00003088-200544020-00003","volume":"44","author":"IH Patel","year":"2005","unstructured":"Patel IH, Zhang X, Nieforth K, Salgo M, Buss N. Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide. Clin Pharmacokinet. 2005;44(2):175\u201386.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"2391_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/bip.20554","volume":"84","author":"RW Payne","year":"2006","unstructured":"Payne RW, Nayar R, Tarantino R, Terzo SD, Moschera J, Di J, et al. Second virial coefficient determination of a therapeutic peptide by self-interaction chromatography. Peptide Science: Original Research on Biomolecules. 2006;84(5):527\u201333.","journal-title":"Peptide Science: Original Research on Biomolecules"},{"issue":"4","key":"2391_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2164\/jandrol.04104","volume":"26","author":"DH Owen","year":"2005","unstructured":"Owen DH, Katz DF. A review of the physical and chemical properties of human semen and the formulation of a semen simulant. J Androl. 2005;26(4):459\u201369.","journal-title":"J Androl"},{"issue":"1","key":"2391_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/156720109787048294","volume":"6","author":"J Neves","year":"2009","unstructured":"Neves J, d, da Silva MV, Gon\u00e7alves MP, Amaral MH, Bahia MF. Rheological properties of vaginal hydrophilic polymer gels. Current Drug Delivery. 2009;6(1):83\u201392.","journal-title":"Current Drug Delivery."},{"key":"2391_CR29","unstructured":"Hochmeister M. Evaluation of Prostate-Specific Antigen (PSA) Membrane tests for the forensic identification of semen. 1997;"},{"issue":"7286","key":"2391_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature08757","volume":"464","author":"AT Haase","year":"2010","unstructured":"Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature. 2010 Mar;464(7286):217\u201323.","journal-title":"Nature"},{"key":"2391_CR31","doi-asserted-by":"crossref","unstructured":"Veazey RS, Ketas TA, Klasse PJ, Davison DK, Singletary M, Green LC, et al. Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249. Proc Natl Acad Sci U S A. 2008\/07\/22 ed. 2008 Jul 29;105(30):10531\u20136.","DOI":"10.1073\/pnas.0802666105"},{"issue":"3","key":"2391_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ejpb.2011.06.007","volume":"79","author":"T Zhang","year":"2011","unstructured":"Zhang T, Sturgis TF, Youan BBC. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission. Eur J Pharm Biopharm. 2011;79(3):526\u201336.","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"2391_CR33","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1021\/acs.molpharmaceut.7b00555","volume":"14","author":"FS Coulibaly","year":"2017","unstructured":"Coulibaly FS, Ezoulin MJ, Purohit SS, Ayon NJ, Oyler NA, Youan BBC. Layer-by-layer engineered microbicide drug delivery system targeting HIV-1 gp120: physicochemical and biological properties. Mol Pharm. 2017;14(10):3512\u201327.","journal-title":"Mol Pharm"},{"issue":"2","key":"2391_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1208\/s12248-013-9546-7","volume":"16","author":"V Agrahari","year":"2014","unstructured":"Agrahari V, Zhang C, Zhang T, Li W, Gounev TK, Oyler NA, et al. Hyaluronidase-sensitive nanoparticle templates for triggered release of HIV\/AIDS microbicide in vitro. AAPS J. 2014;16(2):181\u201393.","journal-title":"AAPS J"},{"issue":"9","key":"2391_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107819","volume":"9","author":"JM Mattsson","year":"2014","unstructured":"Mattsson JM, Ravela S, Hekim C, Jonsson M, Malm J, N\u00e4rv\u00e4nen A, et al. Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activity. PLoS ONE. 2014;9(9): e107819.","journal-title":"PLoS ONE"},{"key":"2391_CR36","unstructured":"Plant TM, Zeleznik AJ. (Eds.). Knobil and Neill\u2019s physiology of reproduction (4th ed.). Academic Press; 2014;1:790\u2013793."},{"issue":"1\u20132","key":"2391_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijpharm.2011.04.004","volume":"413","author":"MR Clark","year":"2011","unstructured":"Clark MR, Aliyar HA, Lee C, won, Jay JI, Gupta KM, Watson KM, et al. Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles. Int J Pharm. 2011;413(1\u20132):10\u20138.","journal-title":"Int J Pharm."},{"issue":"4","key":"2391_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1515\/bc.2010.044","volume":"391","author":"AM LeBeau","year":"2010","unstructured":"LeBeau AM, Kostova M, Craik CS, Denmeade SR. Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer. Biol Chem. 2010;391(4):333\u201343.","journal-title":"Biol Chem"},{"issue":"5","key":"2391_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1034\/j.1399-3011.1999.00141.x","volume":"54","author":"CF Yang","year":"1999","unstructured":"Yang CF, Porter ES, Boths J, Kanyi D, Hsieh MC, Cooperman BS. Design of synthetic hexapeptide substrates for prostate-specific antigen using single-position minilibraries. J Pept Res. 1999;54(5):444\u20138.","journal-title":"J Pept Res"},{"issue":"35","key":"2391_CR40","doi-asserted-by":"publisher","first-page":"25678","DOI":"10.1074\/jbc.M602372200","volume":"281","author":"M Debela","year":"2006","unstructured":"Debela M, Magdolen V, Schechter N, Valachova M, Lottspeich F, Craik CS, et al. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J Biol Chem. 2006;281(35):25678\u201388.","journal-title":"J Biol Chem"},{"issue":"4","key":"2391_CR41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/01.qai.0000185314.56556.c3","volume":"40","author":"M Nelson","year":"2005","unstructured":"Nelson M, Arast\u00e9h K, Clotet B, Cooper DA, Henry K, Katlama C, et al. Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2005;40(4):404\u201312.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"22","key":"2391_CR42","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1056\/NEJMoa035211","volume":"348","author":"A Lazzarin","year":"2003","unstructured":"Lazzarin A, Clotet B, Cooper D, Reynes J, Arast\u00e9h K, Nelson M, et al. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. N Engl J Med. 2003;348(22):2186\u201395.","journal-title":"N Engl J Med"},{"issue":"22","key":"2391_CR43","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMoa035026","volume":"348","author":"JP Lalezari","year":"2003","unstructured":"Lalezari JP, Henry K, O\u2019Hearn M, Montaner JS, Piliero PJ, Trottier B, et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med. 2003;348(22):2175\u201385.","journal-title":"N Engl J Med"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02391-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T16:05:36Z","timestamp":1666713936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02391-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02391-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"23 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"234"}}